source
- RNAi biotech ADARx raises $446 million in IPO, secures $89 million from AbbVieADARx Pharmaceuticals priced its initial public offering at $17 per share, selling more than 26 million shares to raise about $446.3 million. The company also received an additional $89 million th…
- Biomanufacturers Redesign Processes to Blend Emergency Vaccine Readiness with Commercial FlexibilityManufacturers are overhauling their production methods to simultaneously improve rapid vaccine deployment for future health crises and maintain flexible, commercially viable manufacturing networks…